The Board Inter-alia considered and approved the Un-Audited Standalone & Consolidated Financial Results of the Company for the Third Quarter and Nine Months ended on December 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Capital Ltd's board approved its unaudited Q3 FY26 and 9M FY26 results. On a standalone basis, the parent company reported zero revenue from operations and a loss of Rs. 17.31 lakhs in Q3 FY26, with a 9M loss of Rs. 49.01 lakhs (slightly better than Rs. 50.84 lakhs loss in 9M FY25). Standalone other equity stood at negative Rs. 696.79 lakhs as of March 31, 2025, indicating accumulated losses at the parent level. On a consolidated basis, including subsidiaries (Health Care Energy Foods, Unisphere Industries, Butterfly Ayurveda), revenue from operations rose to Rs. 24.34 lakhs in Q3 FY26 (from Rs. 21.96 lakhs YoY) and 9M revenue grew ~30% to Rs. 52.68 lakhs. Consolidated PAT jumped ~56% YoY in Q3 to Rs. 356.16 lakhs and ~76% in 9M to Rs. 1,023.72 lakhs. EPS on a consolidated basis was Rs. 12.37 for the quarter.
The standalone parent company continues to show zero revenue and losses, which is a red flag for minority shareholders reliant on the parent's own performance. However, consolidated profitability remains strong, driven entirely by subsidiaries, and the company is also proposing material related party transactions for FY26-27 through a postal ballot, which shareholders should review carefully before approving.